Tramadol Toxicity and Its Implications for Brain Disorders: A Narrative Review
Journal of Otorhinolaryngology and Facial Plastic Surgery,
Vol. 9 No. 1 (2023),
2 September 2023
https://doi.org/10.22037/orlfps.v9i1.47125
Abstract
Tramadol is widely used in the management of moderate to moderately severe pain due to its unique dual mechanism of action as a weak μ-opioid receptor agonist and as an inhibitor of serotonin and norepinephrine reuptake. However, it seems that this medication may possess neurotoxicity, especially in misuse, overdose, or chronic use. This review highlights current knowledge on the neurotoxic effects of tramadol, outlining the mechanisms of both its acute and chronic effects on seizure induction, serotonin syndrome, oxidative stress, neuroinflammation, and neurotransmitter dysregulation. Patients susceptible to the adverse effects from such neurotoxicity-geriatric, pediatric, or with previous neurological disorders-also come into focus, with personalized clinical approaches being recommended. It also touches on the possible connections of chronic tramadol use with neurodegenerative disorders such as Alzheimer's and Parkinson's diseases and gives the implications for public health and clinical practice. The future directions of research are outlined: large-scale epidemiological studies, biomarker development, alternative pain management strategies, and enhanced regulatory frameworks. This review therefore addresses these gaps to guide safer use of tramadol and improving our understanding of its long-term consequences on brain health.
- Tramadol, Oxidative stress, Neuroinflammation, Neurodegeneration
How to Cite
References
Edinoff, A.N., et al., Full Opioid Agonists and Tramadol: Pharmacological and Clinical Considerations. Anesth Pain Med, 2021. 11(4): p. e119156.
Boun, S.S., O. Omonaiye, and S. Yaya, Prevalence and health consequences of nonmedical use of tramadol in Africa: A systematic scoping review. PLOS Glob Public Health, 2024. 4(1): p. e0002784.
Danso, M. and F. Anto, Factors Associated with Tramadol Abuse: A Cross-Sectional Study Among Commercial Drivers and Assistants in the Accra Metropolitan Area of Ghana. Drugs Real World Outcomes, 2021. 8(3): p. 337-347.
Babahajian, A., et al., Seizure Prevalence and Its Related Factors in Tramadol Intoxication; a Brief Report. Arch Acad Emerg Med, 2019. 7(1): p. e28.
Christie, M.J., Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol, 2008. 154(2): p. 384-96.
Ghoneim, F.M., H.A. Khalaf, A.Z. Elsamanoudy, and A.N. Helaly, Effect of chronic usage of tramadol on motor cerebral cortex and testicular tissues of adult male albino rats and the effect of its withdrawal: histological, immunohistochemical and biochemical study. Int J Clin Exp Pathol, 2014. 7(11): p. 7323-41.
Mobasher, M.A., et al., The effects of tramadol on norepinephrine and MHPG releasing in locus coeruleus in formalin test in rats: a brain stereotaxic study. Iran J Basic Med Sci, 2014. 17(6): p. 419-25.
Arakawa, R., A. Takano, and C. Halldin, Serotonin and Norepinephrine Transporter Occupancy of Tramadol in Nonhuman Primate Using Positron Emission Tomography. Int J Neuropsychopharmacol, 2019. 22(1): p. 53-56.
Sansone, R.A. and L.A. Sansone, Tramadol: seizures, serotonin syndrome, and coadministered antidepressants. Psychiatry (Edgmont), 2009. 6(4): p. 17-21.
Mousavi, K., et al., Mitochondrial dysfunction and oxidative stress are involved in the mechanism of tramadol-induced renal injury. Curr Res Pharmacol Drug Discov, 2021. 2: p. 100049.
Nakhaee, S., et al., A review on tramadol toxicity: mechanism of action, clinical presentation, and treatment. Forensic Toxicology, 2021. 39(2): p. 293-310.
Takeshita, J. and M.H. Litzinger, Serotonin syndrome associated with tramadol. Prim Care Companion J Clin Psychiatry, 2009. 11(5): p. 273.
Khalil, M.A., et al., Degenerative brain changes associated with tramadol use: an optical coherence tomography study. Middle East Current Psychiatry, 2023. 30(1): p. 100.
Lagard, C., et al., Investigation of the Mechanisms of Tramadol-Induced Seizures in Overdose in the Rat. Pharmaceuticals, 2022. 15(10): p. 1254.
Rehni, A.K., I. Singh, and M. Kumar, Tramadol‐induced seizurogenic effect: a possible role of opioid‐dependent γ‐aminobutyric acid inhibitory pathway. Basic & clinical pharmacology & toxicology, 2008. 103(3): p. 262-266.
Boostani, R. and S. Derakhshan, Tramadol induced seizure: A 3-year study. Caspian J Intern Med, 2012. 3(3): p. 484-7.
Talaie, H., et al., Dose-independent occurrence of seizure with tramadol. J Med Toxicol, 2009. 5(2): p. 63-7.
Hassamal, S., K. Miotto, W. Dale, and I. Danovitch, Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures. The American Journal of Medicine, 2018. 131(11): p. 1382.e1-1382.e6.
Francescangeli, J., K. Karamchandani, M. Powell, and A. Bonavia, The Serotonin Syndrome: From Molecular Mechanisms to Clinical Practice. Int J Mol Sci, 2019. 20(9).
Bloms-Funke, P., E. Dremencov, T.I.F.H. Cremers, and T.M. Tzschentke, Tramadol increases extracellular levels of serotonin and noradrenaline as measured by in vivo microdialysis in the ventral hippocampus of freely-moving rats. Neuroscience Letters, 2011. 490(3): p. 191-195.
Mohamed, H.M. and A.M. Mahmoud, Chronic exposure to the opioid tramadol induces oxidative damage, inflammation and apoptosis, and alters cerebral monoamine neurotransmitters in rats. Biomed Pharmacother, 2019. 110: p. 239-247.
Bakr, M.H., et al., Chronic exposure to tramadol induces cardiac inflammation and endothelial dysfunction in mice. Sci Rep, 2021. 11(1): p. 18772.
Mohammadnejad, L., et al., Evaluation of mitochondrial dysfunction due to oxidative stress in therapeutic, toxic and lethal concentrations of tramadol. Toxicol Res (Camb), 2021. 10(6): p. 1162-1170.
Klemmensen, M.M., et al., Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics, 2024. 21(1): p. e00292.
Khatmi, A., et al., Combined molecular, structural and memory data unravel the destructive effect of tramadol on hippocampus. Neuroscience Letters, 2022. 771: p. 136418.
Soltani, R., et al., Tramadol exposure upregulated apoptosis, inflammation and autophagy in PC12 cells and rat’s striatum: An in vitro- in vivo approach. Journal of Chemical Neuroanatomy, 2020. 109: p. 101820.
Smith, J.A., A. Das, S.K. Ray, and N.L. Banik, Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull, 2012. 87(1): p. 10-20.
Sadat-Shirazi, M.S., et al., Tramadol induces changes in Δ-FosB, µ-opioid receptor, and p-CREB level in the nucleus accumbens and prefrontal cortex of male Wistar rat. Am J Drug Alcohol Abuse, 2019. 45(1): p. 84-89.
El-Hadidy, M.A. and A.M. Helaly, Medical and Psychiatric Effects of Long-Term Dependence on High Dose of tramadol. Subst Use Misuse, 2015. 50(5): p. 582-9.
Raj, K., P. Chawla, and S. Singh, Neurobehavioral Consequences Associated with Long Term Tramadol Utilization and Pathological Mechanisms. CNS Neurol Disord Drug Targets, 2019. 18(10): p. 758-768.
Picca, A., et al., Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration. Antioxidants (Basel), 2020. 9(8).
Oh, S.N., et al., Tramadol use and incident dementia in older adults with musculoskeletal pain: a population-based retrospective cohort study. Scientific Reports, 2024. 14(1): p. 23850.
Musich, S., et al., Safety Events Associated with Tramadol Use Among Older Adults with Osteoarthritis. Popul Health Manag, 2021. 24(1): p. 122-132.
Jin, J., Risks of Codeine and Tramadol in Children. JAMA, 2017. 318(15): p. 1514-1514.
Pickering, G., et al., Pharmacological Pain Treatment in Older Persons. Drugs & Aging, 2024. 41(12): p. 959-976.
- Abstract Viewed: 243 times
- PDF Downloaded: 451 times